FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+1.61%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.4B
AUM Growth
+$1.4B
(-8%)
Cap. Flow
-$32.5M
Cap. Flow
% of AUM
-2.32%
Top 10 Holdings %
Top 10 Hldgs %
47.37%
Holding
90
New
7
Increased
27
Reduced
20
Closed
11
Top Buys
| 1 |
AtriCure
ATRC
|
$24.9M |
| 2 |
Keros Therapeutics
KROS
|
$22.2M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
$18.7M |
| 4 |
BCYC
Bicycle Therapeutics
BCYC
|
$16.3M |
| 5 |
FNA
Paragon 28, Inc.
FNA
|
$12.8M |
Top Sells
| 1 |
Aldeyra Therapeutics
ALDX
|
$26.2M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
$25.7M |
| 3 |
Y-mAbs Therapeutics
YMAB
|
$16.5M |
| 4 |
Insmed
INSM
|
$14.4M |
| 5 |
OptimizeRx
OPRX
|
$12M |
Sector Composition
| 1 | Healthcare | 84.7% |
| 2 | Communication Services | 5.48% |
| 3 | Energy | 0.15% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNE
1
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $88.6M | 6.35% | 6,506,038 +242,778 | +4% | +$3.31M |
|
2
Prothena Corp
PRTA
$441M
| $80.2M | 5.74% | 1,622,941 +173,447 | +12% | +$8.57M |
|
|
MODN
3
DELISTED
MODEL N, INC.
MODN
| $76.5M | 5.48% | 2,547,930 +69,398 | +3% | +$2.08M |
|
|
4
AtriCure
ATRC
$1.84B
| $69.9M | 5% | 1,004,989 +357,797 | +55% | +$24.9M |
|
5
Tandem Diabetes Care
TNDM
$845M
| $62M | 4.44% | 411,784 -67,402 | -14% | -$10.1M |
|
|
BCYC
6
Bicycle Therapeutics
BCYC
$511M
| $60.9M | 4.36% | 1,000,783 +268,052 | +37% | +$16.3M |
|
7
Halozyme
HALO
$8.56B
| $60.8M | 4.35% | 1,511,843 +34,347 | +2% | +$1.38M |
|
|
ARNA
8
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $60M | 4.3% | 645,848 -314 | -0% | -$29.2K |
|
9
Omnicell
OMCL
$1.5B
| $55M | 3.94% | 304,895 -49,147 | -14% | -$8.87M |
|
10
Krystal Biotech
KRYS
$4.27B
| $47.6M | 3.41% | 680,170 +46,689 | +7% | +$3.27M |
|
|
XENT
11
DELISTED
Intersect ENT, Inc
XENT
| $46.4M | 3.32% | 1,697,834 -438,989 | -21% | -$12M |
|
|
KRTX
12
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $36.9M | 2.64% | 281,701 +6,057 | +2% | +$793K |
|
13
Ultragenyx Pharmaceutical
RARE
$2.89B
| $34.6M | 2.48% | 411,313 -29,846 | -7% | -$2.51M |
|
14
Codexis
CDXS
$246M
| $34.1M | 2.44% | 1,089,150 +389,434 | +56% | +$12.2M |
|
15
Sutro Biopharma
STRO
$72.7M
| $33.4M | 2.39% | 2,246,588 +55,149 | +3% | +$821K |
|
|
16
Keros Therapeutics
KROS
$618M
| $32.3M | 2.31% | 552,098 +378,888 | +219% | +$22.2M |
|
17
Health Catalyst
HCAT
$239M
| $32.2M | 2.31% | 813,046 +18,086 | +2% | +$717K |
|
18
CareDx
CDNA
$727M
| $31.1M | 2.23% | 683,463 -217,007 | -24% | -$9.87M |
|
19
MEI Pharma
MEIP
$160M
| $30M | 2.14% | 11,217,426 +2,579,951 | +30% | +$6.89M |
|
|
CUTR
20
DELISTED
Cutera, Inc.
CUTR
| $27.1M | 1.94% | 656,873 -111,854 | -15% | -$4.62M |
|
21
Alphatec Holdings
ATEC
$2.35B
| $26.6M | 1.9% | 2,325,485 +550,817 | +31% | +$6.3M |
|
|
TPTX
22
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $26.2M | 1.88% | 549,626 +96,748 | +21% | +$4.61M |
|
23
NeoGenomics
NEO
$1.13B
| $26.1M | 1.87% | 763,907 -292,053 | -28% | -$9.97M |
|
24
Axogen
AXGN
$743M
| $21.4M | 1.53% | 2,285,373 +46,112 | +2% | +$432K |
|
|
25
OptimizeRx
OPRX
$335M
| $19.5M | 1.4% | 313,769 -193,615 | -38% | -$12M |
|